Correlation Between Ningbo MedicalSystem and Sinocelltech

Can any of the company-specific risk be diversified away by investing in both Ningbo MedicalSystem and Sinocelltech at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Ningbo MedicalSystem and Sinocelltech into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Ningbo MedicalSystem Biotechnology and Sinocelltech Group, you can compare the effects of market volatilities on Ningbo MedicalSystem and Sinocelltech and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Ningbo MedicalSystem with a short position of Sinocelltech. Check out your portfolio center. Please also check ongoing floating volatility patterns of Ningbo MedicalSystem and Sinocelltech.

Diversification Opportunities for Ningbo MedicalSystem and Sinocelltech

0.87

Correlation Coefficient

Ningbo MedicalSystem  Sinocelltech

Very poor diversification

The 3 months correlation between Ningbo and Sinocelltech is 0.87. Overlapping area represents the amount of risk that can be diversified away by holding Ningbo MedicalSystem Biotechno and Sinocelltech Group in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Sinocelltech Group and Ningbo MedicalSystem is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Ningbo MedicalSystem Biotechnology are associated (or correlated) with Sinocelltech. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Sinocelltech Group has no effect on the direction of Ningbo MedicalSystem i.e., Ningbo MedicalSystem and Sinocelltech go up and down completely randomly.

Pair Corralation between Ningbo MedicalSystem and Sinocelltech

Assuming the 90 days trading horizon Ningbo MedicalSystem Biotechnology is expected to generate 0.87 times more return on investment than Sinocelltech. However, Ningbo MedicalSystem Biotechnology is 1.15 times less risky than Sinocelltech. It trades about 0.08 of its potential returns per unit of risk. Sinocelltech Group is currently generating about 0.06 per unit of risk. If you would invest  958.00  in Ningbo MedicalSystem Biotechnology on September 26, 2024 and sell it today you would earn a total of  140.00  from holding Ningbo MedicalSystem Biotechnology or generate 14.61% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Strong
Accuracy	100.0%
Values	Daily Returns

Ningbo MedicalSystem Biotechno  vs.  Sinocelltech Group

Ningbo MedicalSystem

Risk-Adjusted Performance

6 of 100

OK

Compared to the overall equity markets, risk-adjusted returns on investments in Ningbo MedicalSystem Biotechnology are ranked lower than 6 (%) of all global equities and portfolios over the last 90 days. Despite somewhat weak basic indicators, Ningbo MedicalSystem sustained solid returns over the last few months and may actually be approaching a breakup point.

Sinocelltech Group

Risk-Adjusted Performance

4 of 100

Modest

Compared to the overall equity markets, risk-adjusted returns on investments in Sinocelltech Group are ranked lower than 4 (%) of all global equities and portfolios over the last 90 days. Despite somewhat weak basic indicators, Sinocelltech sustained solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Ningbo MedicalSystem and Sinocelltech

The main advantage of trading using opposite Ningbo MedicalSystem and Sinocelltech positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Ningbo MedicalSystem position performs unexpectedly, Sinocelltech can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Sinocelltech will offset losses from the drop in Sinocelltech's long position.

The idea behind Ningbo MedicalSystem Biotechnology and Sinocelltech Group pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Center module to all portfolio management and optimization tools to improve performance of your portfolios.